These promising results—from an NIH-funded study that exclusively evaluated Masimo SET ® in a vulnerable, clinically fragile patient population—add to previously published evidence of its strong ...

Masimo (Nasdaq:MASI) today announced new study findings supporting the use of its SET pulse oximetry in critically ill neonates.

Irvine-based medical device maker Masimo announces data from a study showing that its pulse oximetry technology accurately ...

Critical congenital heart diseases, or CCHDs, are a group of life-threatening structural heart defects present at birth.

Most parents are familiar with the so-called “U-examinations.” These are preventive check-ups that monitor the healthy ...

Acquired heart disease include Kawasaki disease, rheumatic valve disease, or arrhythmias, which are usually present with ...